Pontifax
60+Portfolio
Invests in transformative, cutting‑edge life sciences technologies across all development stages, regardless of therapeutic area.
Where they invest
Geography
Portfolio footprintHover a country to explore
- United States of America
- 31.6%
- Israel
- 18.4%
- France
- 7.9%
- Denmark
- 5.3%
- Belgium
- 2.6%
- Other
- 10.4%
Darker countries represent a larger share of the portfolio.
What they back
Industries
- Biotechnology
- 76.3%
- Artificial Intelligence
- 7.9%
- Healthcare Technology
- 7.9%
- Data & Analytics
- 5.3%
- Medical Devices
- 5.3%
- Enterprise Software
- 5.3%
% of all portfolio companies. Industry categories can overlap.
Stages
Stage indicator
No stages listed
Fund details
Funds
Pontifax VI
Vintage 2021 • $404M
Pontifax Global Food and Agriculture Fund II
Vintage 2020 • $302M